European Commission approves transfer of marketing authorisation for Elocta® to Sobi
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that the European Commission (EC) has approved the transfer of…
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that the European Commission (EC) has approved the transfer of…
Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the companies strongly disagree with a U.S. District Cou…
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) today announced the commercial launch of Elocta® (efmoroctocog alfa) in fi…
Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) and Biogen (NASDAQ: BIIB) today announced that the European Commis…
- First therapy to provide prolonged bleeding protection with prophylactic injections every three to five days - - Prod…
GELITA, the official Collagen Protein Sponsor of SupplySideWest, inspires winning solutions – from fortified gummy deliv…
Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those inv…
With a careful eye on the course of individuality that Ulysse Nardin has cultivated since its inception, the manufacture…
Anergis, a company focusing on proprietary allergy vaccines, today reported immunology data from the Phase IIb study of…
The Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced the initiation of a n…